Yahoo Web Search

Search results

1. www.baincapitallifesciences.comBain Capital Life Sciences

   www.baincapitallifesciences.com

   • Cached

   We target four types of investment opportunities: Inflection Capital; Growth Capital; Fallen Angels; and Larger Private Equity Collaborations and New Company Formation. Investments Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe.

   • About Us

     Bain Capital Life Sciences invests in pharmaceutical,...

   • Our People

     Our team draws upon individuals with senior experience in...

   • Strategy

     Bain Capital Life Sciences seeks to create differentiated...

   • Investments

     Bain Capital Life Sciences pursues investments in...

   • News

     Nurix Therapeutics is Part of a Team of International...

   • Contact

     For additional information, please contact...

2. www.baincapital.com › news › 19-billion-raise-bain$1.9 billion raise for Bain Capital’s life sciences fund

   www.baincapital.com › news › 19-billion-raise-bain

   • Cached

   RNA startup ADARx raises $200M from Bain, TCGX to bring RNAi 'to the next level'. Bain Capital, LPis one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live.

3. People also ask

   What is Bain Capital Investing?

   • Bain Capital INVESTING Bain Capital’s life sciences arm has just finished raising $1.9 billion for its third investment fund, including $300 million from current and former partners of the Boston-based private equity firm, and it has begun searching for drug, biotech, and medical device companies where it can invest the money.

   $1.9 billion raised for Bain Capital’s life sciences fund

   www.bostonglobe.com/2021/08/16/business/19-billion-raised-bain-capitals-life-sciences-fund/

   See all results for this question

   Who will Bain Capital Life Sciences target?

   • The types of companies that the 16-person team at Bain Capital Life Sciences will target include, among others, those that need financing to complete clinical trials or a geographic expansion, and public companies whose stocks were beaten down by an unexpected event but still hold significant value.

   $1.9 billion raised for Bain Capital’s life sciences fund

   www.bostonglobe.com/2021/08/16/business/19-billion-raised-bain-capitals-life-sciences-fund/

   See all results for this question

   Who owns Bain Capital Life Sciences?

   • Bain Capital Life Sciences Investors, LLC is the second largest shareholder owning 9.2% of common stock, and OrbiMed Advisors LLC holds about 7.3% of the company stock. A closer look at our ownership figures suggests that the top 11 shareholders have a combined ownership of 51% implying that no single shareholder has a majority.

   X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) most popular amongst individ…

   finance.yahoo.com/news/x4-pharmaceuticals-inc-nasdaq-xfor-145128592.html

   See all results for this question

   What are the largest private equity funds in the life sciences sector?

   • This fund will be among the largest private equity funds in the life sciences sector; it follows a $720 million fund and a $1.1 billion fund that Bain previously raised and deployed in recent years. Some Boston-area recipients of these investments include Cerevel Therapeutics, Nuvalent, Amylyx Pharmaceuticals, and AavantiBio.

   $1.9 billion raised for Bain Capital’s life sciences fund

   www.bostonglobe.com/2021/08/16/business/19-billion-raised-bain-capitals-life-sciences-fund/

   See all results for this question

4. www.biopharmadive.com › news › bain-life-sciencesPrivate equity dives deeper into biotech with nearly $2B Bain ...

   www.biopharmadive.com › news › bain-life-sciences

   • Cached

   Aug 17, 2021 · Boston-based investment firm Bain Capital has raised $1.9 billion in a new fund directed at pharmaceutical, biotechnology and medical device companies. The news was first reported by Endpoints News. This latest life sciences fund, Bain’s third, includes $300 million from current and former partners, according to a spokesperson.

5. pitchbook.com › profiles › fundBain Capital Life Sciences Fund III - PitchBook

   pitchbook.com › profiles › fund

   • Cached

   Dec 20, 2021 · Bain Capital Life Sciences Fund III is a private equity growth expansion fund co-managed by Bain Capital and Bain Capital Life Sciences. The fund is located in Boston, Massachusetts. The fund targets investments in the life science sector. The fund has investment ranging from USD 25 million to USD 100 million. The fund invests for minimum 4 years.

6. www.bostonglobe.com › 2021/08/16 › business$1.9 billion raised for Bain Capital’s life sciences fund

   www.bostonglobe.com › 2021/08/16 › business

   Aug 16, 2021 · Bain Capital’s life sciences arm has just finished raising $1.9 billion for its third investment fund, including $300 million from current and former partners of the Boston-based...

7. www.biospace.com › article › bain-life-sciencesBain Life Sciences Raises $1.9 Billion to Help Fund Promising ...

   www.biospace.com › article › bain-life-sciences

   • Cached

   Aug 17, 2021 · Published: Aug 17, 2021 By Vanessa Doctor, RN. The life sciences arm of Boston-based private equity firm Bain Capital has successfully raised $1.9 billion to fund future projects that involve medical, drug, and biotechnology projects.